Catalyst Wire Dossier Catalyst Wire Dossier

FluBHPVE6E7

· BlueSky Immunotherapies GmbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FluBHPVE6E7, covering 2025-02-13 to 2025-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women [Phase 1]

See pricing